Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study.
Angela C ShoreHelen Martina ColhounAndrea NataliCarlo PalomboFaisel KhanGerd ÖstlingKunihiko AizawaCecilia KennbäckFrancesco CasanovaMargaretha PerssonKim GoodingPhillip E GatesHelen LookerFiona DoveJill BelchSilvia PinnolaElena VenturiMichaela KozakovaIsabel GoncalvesJasmina KravicHarry BjörkbackaJan Nillsonnull nullPublished in: Diabetes care (2018)
Our observations demonstrate that markers of inflammation and endothelial stress reflect CV risk in subjects with T2D with manifest CVD, whereas the risk for CV events in subjects with T2D without manifest CVD is primarily related to the severity of atherosclerosis.